Sanjay Rajanikant Mehta
Direktor/Vorstandsmitglied bei Zuventus Healthcare Ltd.
Vermögen: 158 $ am 30.09.2021
Aktive Positionen von Sanjay Rajanikant Mehta
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Zuventus Healthcare Ltd.
 Zuventus Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Zuventus Healthcare Ltd operates as pharmaceutical company. The company was founded in 15th July, 2002 and is headquartered in Mumbai, India. | Direktor/Vorstandsmitglied | 11.05.2011 | - |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | 01.04.1989 | - |
Karriereverlauf von Sanjay Rajanikant Mehta
Ausbildung von Sanjay Rajanikant Mehta
| University of Pune | Undergraduate Degree |
Statistik
International
| Indien | 4 |
Operativ
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Zuventus Healthcare Ltd.
Zuventus Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Zuventus Healthcare Ltd operates as pharmaceutical company. The company was founded in 15th July, 2002 and is headquartered in Mumbai, India. | Health Technology |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Börse
- Insiders
- Sanjay Rajanikant Mehta
- Erfahrung